Search results for: Oncology
Filter search results
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
…addition, case study analyses revealed significant possible savings, such as the €7.1 billion that could be saved during the period 2016-2020, through increased generic and biosimilar competition in the oncology…
New NICE Manual for Health Technology Evaluations: A Critical Discussion on the Most Relevant Changes (or Lack Thereof)
23 February 2022
…regimens in oncology; and clarify the meanings of absolute and proportional shortfall with examples, in early stages of the review). OHE has responded to both consultations, and in a previous…
OHE is pleased to appoint two Senior Visiting Fellows: Professor David Parkin and Professor Lou Garrison
5 October 2016
…Evidence Generation Risk-Sharing Agreements Between Pharmaceutical Manufacturers and Payers Personalised Medicine and the Value of Molecular Diagnostics Governance models for real-world evidence The Expanding Value Footprint of Oncology Treatments Lou…
Value and Cancer: Journal of Cancer Policy Special Issue
25 January 2017
…J.C., Hernandez-Villafuerte, K., Shah, K., Mestre-Ferrandiz, J., Garrison, L. and Towse, A., 2014. The Expanding Value Footprint of Oncology Treatments. Consulting Report. London: Office of Health Economics. Richards, M., 2011. Achieving…
Dementia: The R&D Landscape
1 November 2015
…observations include: R&D costs are higher for neurology and Alzheimer’s disease (AD) (as well as respiratory and oncology) than other therapy areas Higher costs are likely due to lower success…
Comparing the Cancer-Specific EORTC-8D and the Generic EQ-5D-3L
4 January 2017
…life gains. Reference: Lorgelly, P.K., Doble, B., Rowen, D. Brazier, J., 2016. Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L. Quality of Life Research. …
OHE at ISPOR Europe 2016: Risk-sharing, Differential Pricing, the Cancer Drugs Fund, and Patient Reported Outcomes
26 October 2016
…and Simona Bianchi (ABPI). The Cancer Drugs Fund (CDF) was created in 2010 to pay for oncology indications that were not approved by the National Institute for Health and Care…
Leukaemia: Towards Control
6 January 1980
Cancer < 1 min read|01/06/1980 Until the end of the 1960s leukaemia killed about 400 children annually in the United Kingdom. Excluding infant deaths (that is, those occurring in the…
Early Diagnosis of Cancer of the Cervix
1 July 1968
Cancer < 1 min read|01/07/1968 ALTHOUGH cervical cancer causes only 1 per cent of female deaths, it is responsible for almost one quarter of all deaths from cancer amongst women…